HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 86 filers reported holding HOMOLOGY MEDICINES INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $63,000 | -22.2% | 20,826 | -6.6% | 0.00% | – |
| Q4 2021 | $81,000 | -55.2% | 22,291 | -2.9% | 0.00% | -100.0% |
| Q3 2021 | $181,000 | +5.8% | 22,958 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $171,000 | -8.1% | 23,505 | +18.7% | 0.00% | 0.0% |
| Q1 2021 | $186,000 | -16.6% | 19,810 | +0.3% | 0.00% | 0.0% |
| Q4 2020 | $223,000 | +2.3% | 19,758 | -2.8% | 0.00% | 0.0% |
| Q3 2020 | $218,000 | -31.0% | 20,325 | -2.2% | 0.00% | -50.0% |
| Q2 2020 | $316,000 | +38.6% | 20,787 | +41.6% | 0.00% | +100.0% |
| Q1 2020 | $228,000 | -29.0% | 14,676 | -5.5% | 0.00% | 0.0% |
| Q4 2019 | $321,000 | +13.4% | 15,525 | -0.8% | 0.00% | 0.0% |
| Q3 2019 | $283,000 | -6.6% | 15,656 | +1.3% | 0.00% | 0.0% |
| Q2 2019 | $303,000 | -0.3% | 15,460 | +41.1% | 0.00% | 0.0% |
| Q1 2019 | $304,000 | +20.2% | 10,954 | -3.1% | 0.00% | 0.0% |
| Q4 2018 | $253,000 | +60.1% | 11,310 | +63.2% | 0.00% | 0.0% |
| Q3 2018 | $158,000 | +13.7% | 6,930 | +1.8% | 0.00% | – |
| Q2 2018 | $139,000 | – | 6,805 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 4,535,919 | $16,511,000 | 3.10% |
| Vida Ventures Advisors, LLC | 770,845 | $2,806,000 | 1.05% |
| Vivo Capital, LLC | 853,143 | $3,105,000 | 0.19% |
| AAF Wealth Management, LLC | 47,501 | $173,000 | 0.12% |
| OUP Management Co., LLC | 64,000 | $233,000 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 195,596 | $712,000 | 0.09% |
| Temasek Holdings (Private) Ltd | 5,650,996 | $20,570,000 | 0.07% |
| Bellevue Group AG | 1,737,122 | $6,323,000 | 0.06% |
| XTX Topco Ltd | 26,212 | $95,000 | 0.05% |
| Virtus ETF Advisers LLC | 37,588 | $137,000 | 0.05% |